Back to SYRE

ADAGE CAPITAL PARTNERS GP, L.L.C. → SYRE

ADAGE CAPITAL PARTNERS GP, L.L.C. SYRE Position History

Spyre Therapeutics, Inc. • Healthcare

Quarters held
2
Latest value
$157.4M
Q3 2026
Peak value
$157.4M
First seen
Q2 2026

Dollar value over time

Show data table
PeriodPosition value
Q2 2026$152.9M
Q3 2026$157.4M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$157.4M1.77M——
Q2 2026$152.9M1.72M——

Other funds holding SYRE

Other ADAGE CAPITAL PARTNERS GP, L.L.C. positions

NVDA

NVIDIA CORPORATION

$4.8B
NVDA

NVIDIA CORPORATION

$4.4B
AAPL

APPLE INC

$4.2B
NVDA

NVIDIA CORPORATION

$4.2B
NVDA

NVIDIA CORPORATION

$3.9B
AAPL

APPLE INC

$3.8B
AAPL

APPLE INC

$3.6B
AAPL

APPLE INC

$3.3B